DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Edurant (Rilpivirine) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Edurant (Rilpivirine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (16)
Death (4)
Life Threatening Events (7)

Reports by Reaction Type

Rash Generalised (6)Pyrexia (6)Abortion Spontaneous (4)Cystic Lymphangioma (4)Renal Failure Acute (4)Nausea (3)Loss of Consciousness (3)Blood Creatinine Increased (3)CD4 Lymphocytes Decreased (1)Glomerular Filtration Rate Decreased (1)Intensive Care (1)Blood Lactate Dehydrogenase Increased (1)

Possible Edurant side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient:

Reactions: Cystic Lymphangioma, Maternal Exposure During Pregnancy, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Prezista
    Indication: Maternal Exposure Timing Unspecified

Edurant
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified



Possible Edurant side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient:

Reactions: Cystic Lymphangioma, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Edurant
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Prezista
    Indication: Maternal Exposure Timing Unspecified



Possible Edurant side effects in male

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-07-12

Patient: male

Reactions: Intensive Care

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Edurant



Possible Edurant side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: male, weighing 64.9 kg (142.7 pounds)

Reactions: Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epzicom
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-04-23
    End date: 2012-04-28

Lisinopril
    Administration route: Oral
    Indication: Hypertension
    Start date: 2012-03-19
    End date: 2012-05-29

Edurant
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-04-23
    End date: 2012-04-28



Possible Edurant side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12

Patient: 43 year old male, weighing 65.9 kg (145.0 pounds)

Reactions: CD4 Lymphocytes Decreased, Glomerular Filtration Rate Decreased, Nausea, Blood Lactate Dehydrogenase Increased, Blood Triglycerides Increased, Loss of Consciousness, Blood Creatinine Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Edurant
    Dosage: 25mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-23
    End date: 2012-04-28

Epzicom
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-23
    End date: 2012-04-28

Other drugs received by patient: Lisinopril



Possible Edurant side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-30

Patient: male

Reactions: Rash Generalised, Pyrexia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Intelence
    Administration route: Oral
    Indication: HIV Infection

Edurant
    Administration route: Oral
    Indication: HIV Infection



Possible Edurant side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-24

Patient: male

Reactions: Rash Generalised, Pyrexia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Edurant



Possible Edurant side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24

Patient: 43 year old male

Reactions: Nausea, Blood Creatinine Increased, Renal Failure Acute, Loss of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Edurant
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Epzicom
    Indication: Product Used FOR Unknown Indication



Possible Edurant side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-23

Patient: male

Reactions: Rash Generalised, Pyrexia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Edurant
    Administration route: Oral
    Indication: HIV Infection

Intelence
    Administration route: Oral
    Indication: HIV Infection

Prezista
    Indication: HIV Infection



Possible Edurant side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-11

Patient: 43 year old male

Reactions: Nausea, Blood Creatinine Increased, Renal Failure Acute, Loss of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Edurant
    Dosage: 25mg per day
    Indication: Product Used FOR Unknown Indication

Epzicom
    Dosage: 1tab per day
    Indication: Product Used FOR Unknown Indication



Possible Edurant side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-18

Patient: male

Reactions: Rash Generalised, Pyrexia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Intelence
    Administration route: Oral
    Indication: HIV Infection

Edurant
    Administration route: Oral
    Indication: HIV Infection



Possible Edurant side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-18

Patient: male

Reactions: Rash Generalised, Pyrexia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Edurant
    Indication: HIV Infection

Prezista
    Indication: HIV Infection



Possible Edurant side effects in male

Reported by a physician from United States on 2012-04-18

Patient: male

Reactions: Rash Generalised, Pyrexia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Edurant



Possible Edurant side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-01

Patient:

Reactions: Cystic Lymphangioma, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Edurant
    Indication: Maternal Exposure Timing Unspecified

Prezista
    Indication: Maternal Exposure Timing Unspecified



Possible Edurant side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-27

Patient:

Reactions: Cystic Lymphangioma, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Prezista
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Edurant
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified



Possible Edurant side effects in male

Reported by a physician from United States on 2011-11-07

Patient: male, weighing 85.3 kg (187.6 pounds)

Reactions: Pancreatitis, Lipase Increased

Drug(s) suspected as cause:
Edurant

Other drugs received by patient: Mirtazapine; Truvada; Norco; Tramadol HCL; Bactrim; Ferrous Sulfate TAB; Fluconazole

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017